Explore our leading range of therapeutic and antibacterial solutions designed to provide active relief, microflora balance, and premium comfort for adult feminine hygiene.




For decades, the global market for feminine hygiene was dominated by passive absorption products. Traditional pads were engineered primarily to manage menstrual flow using wood pulp, superabsorbent polymers (SAP), and plastic backing sheets. However, as the demographic of the modern adult woman shifts toward proactive wellness, self-care, and preventative medicine, the demand for high-performance, therapeutic, and medicated feminine pads for adult women's use has surged exponentially.
Today, adult women face dynamic lifestyle challenges—ranging from prolonged sitting in corporate environments and high-intensity fitness routines to hormonal shifts during postpartum and menopausal stages. These factors disrupt the delicate vaginal microenvironment, leading to common conditions such as Bacterial Vaginosis (BV), yeast infections, contact dermatitis, and odor concerns. Consequently, modern feminine pads are no longer just hygiene commodities; they have evolved into advanced medical-grade delivery systems that protect, soothe, and actively treat gynecological discomforts.
From a commercial perspective, the market for adult feminine pads is experiencing a significant compound annual growth rate (CAGR). B2B buyers, including pharmaceutical distributors, healthcare chains, and private label brands, are shifting their sourcing strategies. There is a marked preference for manufacturers that hold medical device certifications (such as ISO 13485) over standard cosmetic-grade factories. This shift is driven by stricter regulatory frameworks worldwide and a growing consumer skepticism toward synthetic fragrances and chemical additives that cause vulvar irritation.
To fully appreciate the utility of advanced feminine pads for adult women's use, it is vital to analyze the diverse physiological and lifestyle scenarios where standard pads fall short, and where specialized therapeutic pads provide critical relief.
Bacterial Vaginosis is the most common vaginal infection among adult women of reproductive age. Characterized by a disruption of the normal lactobacilli-dominated flora and an overgrowth of anaerobic bacteria, BV causes discomfort, itching, and distinct odor. Medicated pads, such as the Zimeishu Silver-Ion Pad, act as a continuous-release therapeutic system. The silver ions disrupt the cellular membranes of pathogenic bacteria without harming the natural flora, offering a non-invasive, localized alternative or complement to oral antibiotics.
The postpartum period (puerperium) demands exceptional perineal care. Following childbirth, women experience lochia discharge for several weeks. During this time, the vaginal canal and perineum are highly sensitive, bruised, or sutured. Standard plastic-heavy pads trap moisture and heat, creating a breeding ground for bacterial infections. Medical-grade, breathable, antibacterial pads facilitate healing by maintaining a dry, sterile environment, reducing the risk of ascending uterine infections, and soothing inflamed tissues.
During perimenopause and menopause, declining estrogen levels lead to vulvovaginal atrophy (thinning, drying, and inflammation of the vaginal walls). This condition increases susceptibility to micro-tears, localized irritation, and urinary tract infections (UTIs). Feminine pads designed for this demographic emphasize intense breathability, pH-balanced contact layers, and gentle botanical infusions that restore moisture balance and prevent friction-induced discomfort during daily activities.
Modern adult women lead highly active and mobile lives. Long working hours, frequent travel, and athletic pursuits mean that pads are worn for extended periods. Friction, sweat, and restricted airflow can lead to chafing and odor build-up. High-tech feminine pads utilize advanced moisture-wicking top sheets and odor-neutralizing core technologies (rather than masking perfumes) to ensure long-lasting freshness, confidence, and skin integrity.
Founded in 1995, Shaanxi Wanan Pharmaceutical Co., Ltd is a modern Pharmaceutical enterprise incorporating with science research, production and sales. With a fixed assets of about RMB 65 million Yuan (About USD 8 million) and an annual sales volume of over RMB 50 million Yuan ( About USD 6 million), Wanan Pharmaceutical has currently over 300 employees, 50% of which are medical professionals, including a scientific research group consisting of 5 medical doctors and 11 masters, an expert group consisting of more than 70 gynecological doctors.
Zimeishu silver-ion gynecological pad is Wanan’s major product and has prominent effect on preventing and treating gynecological inflammations. It has passed ISO 9001: 2000, the international quality standard and ISO13485:2003, the international medical equipment standard. Now, the sales network has stretched to most large and medium cities in China and has won favors of female over 6 million.
By combining traditional gynecological wisdom with modern biotechnology, Wanan Pharmaceutical ensures that every batch of Zimeishu pads meets rigid pharmaceutical-grade criteria. Our state-of-the-art cleanrooms and automated packaging systems eliminate contamination risks, delivering a product that healthcare professionals confidently recommend.
The manufacturing and design of feminine pads for adult women's use are undergoing rapid technological shifts. Companies that anticipate these trends will capture significant market share in the coming decade. Here are the key trends defining the future of the industry:
Consumers are demanding transparency in material sourcing. The industry is moving away from chlorine-bleached wood pulp and synthetic top sheets toward certified organic cotton, bamboo fiber, and bioplastics derived from cornstarch. These materials minimize the carbon footprint and significantly reduce the risk of contact allergies and chemical absorption through the highly permeable vulvar skin.
One of the most exciting frontiers in feminine care is the integration of diagnostic indicators. Future feminine pads will feature built-in test strips that change color in response to changes in vaginal pH or the presence of specific biomarkers. This will allow adult women to screen for infections like BV or yeast overgrowth at home, empowering them to seek targeted medical advice early.
Building on the success of silver-ion technology, researchers are exploring the use of micro-encapsulated active ingredients, such as probiotics, lactic acid, and anti-inflammatory herbal extracts. These compounds are engineered to release slowly upon contact with body heat and moisture, providing continuous therapeutic support throughout the day.







